Project Grant R01DA064651
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $2,107,844 on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal mixed-methods study of nicotine pouch adoption and use patterns among U.S. adults. The research combines a nationally representative longitudinal survey with qualitative interviews to examine who uses nicotine pouches, reasons for adoption,...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $1.413 million on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop, refine, and test a telehealth-delivered motivational interviewing intervention for young adults who use electronic nicotine delivery systems (ENDS). The project will develop and test a cessation-induction intervention designed to prompt quit attempts in...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $1,411,502 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test evidence-based communication messages aimed at preventing escalation in e-cigarette use frequency among youth who currently use e-cigarettes infrequently. The project will employ a multi-tiered approach to design targeted prevention messages for...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, operating as RBHS-School of Nursing, $1,265,388 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to examine how product features in cannabis vape product marketing influence young adult use behaviors and risk perceptions. The project conducts a large-scale content analysis to identify and categorize product features conveyed in advertisements of leading cannabis vape...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $431,750 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 1, 2025, with completion targeted for June 30, 2027. This research project will conduct a multi-method investigation into premium cigar use patterns and marketing exposure to address significant gaps in evidence regarding public health impacts. The...
- The National Institute on Drug Abuse awarded Rutgers, The State University of New Jersey (RBHS-School of Nursing) $515,211 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on post-overdose treatment gaps and prevention opportunities in high-risk youth. The research examines nonfatal drug overdoses in adolescents and young adults to identify barriers to behavioral health treatment connection and to generate evidence for tailored prevention...
- The National Institute on Drug Abuse awarded Duke University $722,472 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized, double-blinded study examining very low nicotine content cigarettes as a smoking cessation intervention for individuals with chronic back pain. The research addresses high comorbidity between tobacco smoking and chronic pain, where nicotine's mild anti-nociceptive effects create powerful negative reinforcement and...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $431,750 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to examine the youth appeal of hemp-derived intoxicating cannabis product marketing on social media. The award funds research into how delta-8 THC, THC-A, THC-P, and related products are marketed to youth on Instagram, TikTok, and YouTube. The project will systematically...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $642,253 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct high-precision mapping of sex hormone modulation of reward value computations in opioid addiction. The research addresses disparities in medications for opioid use disorder treatment, which fails in a sizable proportion of patients, particularly female patients...
- The National Institute on Drug Abuse awarded the Research Foundation For Mental Hygiene, Inc. (operating through its New York State Psychiatric Institute division) $195,804 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a five-year research project examining how cannabis influences nicotine use among young and emerging adults (ages 18–35) who use electronic nicotine delivery systems. The study integrates human laboratory methods with...
The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, School of Nursing, $722,948 on September 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial examining the effects of tailored education about low-nicotine cigarettes on adult smokers' beliefs and behaviors. The research addresses a public health gap: U.S. adults conflate the addictive properties of nicotine with the health harms of tobacco combustion. Low-nicotine cigarettes marketed as having "95% less nicotine" risk reinforcing this misperception, potentially causing continued smoking rather than cessation, avoidance of evidence-based nicotine replacement therapy, or switching from non-combusted tobacco products to low-nicotine cigarettes. The study will estimate the prospective population-level impact of tailored education on low-nicotine cigarettes in a national sample of adult cigarette smokers while capturing possible unintended effects. Work is performed in Newark, New Jersey. The project period runs through May 31, 2031. This is a Project Grant, the standard assistance type for NIDA-supported research, supporting basic, clinical, translational, and implementation research to develop knowledge and approaches for prevention, diagnosis, and treatment of drug use, misuse, and addiction.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $722.9k | 9/2/26 |